Genmab A/S (GMAB): Leading Innovation in Antibody Therapeutics

Yahoo FinanceOct 17 20:57

Is the Options Market Predicting a Spike in Genmab (GMAB) Stock?

BarchartOct 16 22:46

Genmab Analyst Ratings

BenzingaOct 16 19:09 · Ratings

H.C. Wainwright Maintains Genmab(GMAB.US) With Buy Rating, Maintains Target Price $50

Futu NewsOct 16 18:31 · Ratings

Genmab's Strong Performance and Strategic Positioning: A Buy Rating With $50 Price Target

TipRanksOct 16 18:25 · Ratings

Johnson & Johnson Posts Q3 Beat; Lowers Earnings Guidance Amid M&A Impact

Seeking AlphaOct 15 19:52